Skip to main content
. 2000 Mar 21;97(7):3485–3490. doi: 10.1073/pnas.070550797

Figure 3.

Figure 3

OVA-BiP hybrid peptide/hsp70 complex induces strong CTL response against a HSV antigen in mice. (a) CTL responses after immunization with hsp70 + HSV-BiP hybrid peptide complex, hsp70 + HSV, TiterMax (TM) + HSV-BiP hybrid peptide, TiterMax + HSV, HSV-BiP hybrid peptide alone, or HSV alone. Results are representative of five experiments. (b) CTL induction in a dose-response evaluation keeping a fixed ratio of hsp70/HSV-BiP hybrid peptide. Results are representative of two experiments. (c) CTL responses in a dose-response evaluation by using a constant amount of hsp70 and decreasing amounts of HSV-BiP hybrid peptide. Results are representative of two experiments.